These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7354648)

  • 21. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple complications in multiple myeloma.
    Basi S; Schulman G; Fogo AB
    Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K; Cheung CK; Sheaff M; Fuggle W; Kamel D; Nakoinz S; Hutchison CA; Cook M; Stoves J; Bradwell AR; Cockwell P
    J Clin Pathol; 2010 Oct; 63(10):884-7. PubMed ID: 20876319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe renal failure in multiple myeloma.
    Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
    Clin Nephrol; 1981 Apr; 15(4):206-10. PubMed ID: 7237869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple myeloma in end-stage renal disease.
    Penfield JG
    Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of renal insufficiency in patients with multiple myeloma].
    Vulić D; Radlović O; Stanojcić A; Radmilović A; Rajić M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():53-5. PubMed ID: 9102930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India.
    Prakash J; Mandal AK; Vohra R; Wani IA; Hota JK; Raja R; Singh U
    Ren Fail; 2009; 31(4):267-71. PubMed ID: 19462274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C; Ardiet C; Bret M; Laville M; Fiere D; Tranchand B; Fouque D
    J Nephrol; 2002; 15(6):684-9. PubMed ID: 12495285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
    Hutchison CA; Cockwell P; Reid S; Chandler K; Mead GP; Harrison J; Hattersley J; Evans ND; Chappell MJ; Cook M; Goehl H; Storr M; Bradwell AR
    J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
    Raab MS; Breitkreutz I; Hundemer M; Benner A; Klaus J; Hegenbart U; Moehler T; Ho AD; Zeier M; Goldschmidt H
    Haematologica; 2006 Nov; 91(11):1555-8. PubMed ID: 17082013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmapheresis and hemodialysis in the treatment of acute renal failure in multiple myeloma.
    Kes P; Pecanić Z; Getaldić B
    Acta Med Croatica; 1995; 49(1):39-42. PubMed ID: 7633177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1990 Aug; 150(8):1693-5. PubMed ID: 2383164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal transplantation in a patient with multiple myeloma and light chain nephropathy.
    Briefel GR; Spees EK; Humphrey RL; Hill GS; Saral R; Zachary JB
    Surgery; 1983 Apr; 93(4):579-84. PubMed ID: 6403997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance hemodialysis in myeloma kidney disease.
    Vaziri ND; Goldman R; Schultze RG; Lee DB; Rosen SM
    West J Med; 1977 Feb; 126(2):91-4. PubMed ID: 847982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of multiple myeloma and its complications].
    Avvisati G; Pulsoni A; Petrucci MT; Tribalto M
    Recenti Prog Med; 1990 Oct; 81(10):642-50. PubMed ID: 2291008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple myeloma with renal failure. A case for intensive treatment.
    Harris DC; Ibels LS; Ravich RB; Isbister JP; Wells JV
    Aust N Z J Med; 1983 Apr; 13(2):163-7. PubMed ID: 6577835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
    Krejcí M; Doubek M; Adam Z; Hájek R; Vorlícek J; Mayer J
    Vnitr Lek; 1997 Nov; 43(11):756-8. PubMed ID: 9650509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.